Title of article
Efficacy of substituting innovator propafenone for its generic formulation in patients with atrial fibrillation
Author/Authors
Amit، نويسنده , , Guy and Rosen، نويسنده , , Amit and Wagshal، نويسنده , , Avraham B. and Bonneh، نويسنده , , Dan Y. and Liss، نويسنده , , Tzvika and Grosbard، نويسنده , , Aviva and Ilia، نويسنده , , Reuven and Katz، نويسنده , , Amos، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2004
Pages
3
From page
1558
To page
1560
Abstract
The clinical outcomes of 114 patients with atrial fibrillation who had been treated with the innovator propafenone, and in whom the drug was then replaced with generic propafenone because of cost containment, were compared. The generic formulation was found to be at least as safe and effective as the innovator drug, with regard to atrial fibrillation recurrence, emergency room and hospital admissions, and necessity for concomitant therapy.
Journal title
American Journal of Cardiology
Serial Year
2004
Journal title
American Journal of Cardiology
Record number
1897621
Link To Document